Skip to main content
Top of the Page

Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma


In the latest episode of The HemOnc Pulse, Graham Collins, MBBS, MA, MRCP, FRCPath, DPhil, a lymphoma specialist at Oxford Cancer and Haematology Centre, discusses the findings from the HoLISTIC Consortium, and what he thinks about checkpoint inhibitors upfront in the treatment of Hodgkin lymphoma, with host Chadi Nabhan, MD, MBA, FACP.

Listen to the episode HERE.

Catch up on earlier episodes of The HemOnc Pulse here.

Back to Top